5-HT3 receptor antagonists.
Tyers
M B
MB
Department of Neuropharmacology, Glaxo Group Research Ltd, Hertfordshire, UK.
D000818:Animals; D001008:Anxiety Disorders / Q000188:drug therapy; D003072:Cognition Disorders / Q000188:drug therapy; D006801:Humans; D011618:Psychotic Disorders / Q000188:drug therapy; D011985:Receptors, Serotonin / Q000187:drug effects* / Q000502:physiology; D019966:Substance-Related Disorders / Q000188:drug therapy
D011985:Receptors, Serotonin